Virbac SA develops, manufactures, and sells medicines and vaccines to enhance the health of food-producing animals. The company’s products comprise Activyl, a spot-on solution used to treat and prevent flea infestations in dogs and cats; Activyl Tick Plus, a spot-on solution; Agrimin, a food supplement for cattle; Browse Plus, a food supplement; Circovirus vaccine, a vaccine against porcine circovirus; Cortavance, a hydrocortisone aceponate-based corticoid spray; Curacef duo, an injectable suspension; Easotic for otitis in dogs; Ectoadvance Plus, a topical external parasiticide; and Effipro duo, a spot-on solution for dogs and cats. Its products also include Effitix to treat tick, flea, and mosquito infestations in dogs; Epiotic, an ear cleanser; Equimax and Eraquell, a horse wormer; Floron to treat respiratory diseases in cattle; Iverhart, a chewable tablet; Milpro, an internal parasiticide tablet; Multimin, a trace element injectable supplement; Neoprinil, an eprinomectin-based pour-on solution; Nutribond, a palatable oral solution; Nutri-plus gel, a food supplement; and Orastrip, a diagnostic test. In addition, its products comprise Ostovet, a food supplement; Prinovox, a ectoparasiticide; Pronefra, a food supplement; Rilexine, a cephalexin-based antibiotic; Sentinel Flavor Tabs and Sentinel Spectrum, a polyvalent parasiticide tablet; Soloxine, a hormone prescribed for treating canine hypothyroidism; Speed, a range of rapid diagnostic tests; Speed Trio FeLV/FIV/Corona, a combined diagnostic test; Suigen, a range of swine vaccines; Suprelorin, a deslorelin-based implant for the induction of temporary infertility in male dogs; Veterin 50%, a spectrum antibiotic; Vet Complex/Veterinary HPM, a petfood; Virbagest, an altrenogest-based progestin; Zenifel, a fogger and spray; and Zoletil, a multi-species general anaesthetic. Further, it provides contract manufacturing services. Virbac SA was founded in 1968 and is headquartered in Carros, France.
São Paulo, BR
4,781 (est)

Virbac Locations

São Paulo, BR

Virbac Metrics

Virbac Summary

Founding Date


Market capitalization

€1.23 B

Closing share price


Virbac Market Value History